How we make money — and what stays clean.
Last updated: May 18, 2026
You're entitled to know how a publication you read makes its money. Most magazines bury this in a 4,000-word policy nobody opens. We're going to keep it short and clear.
What we do not do
- No supplement-brand sponsorships. No supplement company, hormone clinic, peptide vendor, or nutraceutical brand pays us to write favorably about their product. Not now, not ever. It's the easiest pitch this niche gets — and we say no.
- No pharmaceutical-brand sponsorships. Same rule.
- No paid placement in articles. If a product is named or recommended in a Sunday letter or pathway page, it's because we believe it earned the recommendation based on the research.
- No selling your email. Your inbox is sacred. Your data stays with us. We use MailerLite to deliver the Sunday letter; no third-party data broker has access.
What we do
Reader-funded operations
The Sunday letter is free. The site is free. Some of you have asked how to support the work directly. The honest answer right now: forward a letter to one woman you love. That's the highest-leverage thing you can do. Future plans include a paid premium tier and an inner-circle community — when those launch they'll be optional and disclosed.
Affiliate links — disclosed every time
Some links on this site are affiliate links. When you click one and make a purchase, we may earn a small commission at no extra cost to you. We disclose this at the point of the link, not in fine print at the bottom.
The standards we hold ourselves to on affiliate links:
- We only link to products we'd be willing to put our name on in writing.
- The commission doesn't change the recommendation. We've turned down higher-commission affiliate offers for products we don't believe in.
- If a vendor's product changes for the worse, we either update the article or remove the link.
- Affiliate links are clearly identified — usually via the phrase "affiliate link" near the call-to-action, or a disclosure at the start of the article when the affiliate relationship is structurally important to the piece.
Display advertising
We may run Google AdSense or similar contextual ads on some non-pathway, non-letter pages. These are clearly marked. We do not run pop-ups, interstitials, or auto-play video ads.
Future revenue streams (disclosed in advance)
- A paid premium tier of the Sunday letter (planned). Content gated to subscribers; free tier remains substantial.
- Original courses and downloadable guides (planned). Priced fairly. Free letter remains free.
- A small community / inner-circle (planned). Annual membership. Optional.
- Print collection / book deal (long-term).
What you can rely on
If we recommend an intervention — HRT, a supplement form, a particular kind of glucose monitor, a financial product — we will:
- Cite the research that informs the recommendation, by name, with at least the study author and year so you can find it.
- Flag what the research did not measure, what's still controversial, and where reasonable clinicians disagree.
- Disclose any financial relationship to the product or its manufacturer.
- Refer you to a qualified clinician for any medical decision. Articles inform; they don't prescribe.
Editorial standards
Our full editorial standards — fact-checking, source quality, what we'll and won't cover, how we handle corrections — are at /editorial-standards.html. Our masthead and contributor info is at /editorial-team.html.
Contact
Questions about a specific affiliate relationship, a citation, or anything else? Reply to any Sunday letter — those go directly to Alexander. Or email hello@afterfortyfeel.com.
After Forty Feel is published by EndCreations Studio. Independent. Reader-funded. Research-led.